This inventor holds 1 USPTO granted patent. Top assignees: Biofront Therapeutics (Beijing) Co., Ltd., Rk Pharmtech (Beijing) Ltd.. Active years: 2024.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2024
Title: Shuo Gu - Innovator in Cathepsin L Inhibitors
Introduction
Shuo Gu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Cathepsin L (CatL). His innovative work has the potential to impact the treatment of various diseases related to this enzyme.
Latest Patents
Shuo Gu holds a patent for Cathepsin L inhibitors. The patent details a plurality of compounds capable of inhibiting Cathepsin L. Additionally, it provides a composition that includes at least one of these compounds. The patent also outlines a method for treating or preventing one or more CatL-related diseases in a subject, which may involve administering the composition to the subject. He has 1 patent to his name.
Career Highlights
Throughout his career, Shuo Gu has worked with notable companies in the pharmaceutical sector. He has been associated with Biofront Therapeutics (Beijing) Co., Ltd. and Rk Pharmtech (Beijing) Ltd. His work in these organizations has furthered the development of innovative therapeutic solutions.
Collaborations
Shuo Gu has collaborated with several professionals in his field, including Lichao Fang and Yayi Wang. These collaborations have contributed to the advancement of research and development in the area of Cathepsin L inhibitors.
Conclusion
Shuo Gu is a dedicated inventor whose work on Cathepsin L inhibitors showcases his commitment to advancing medical science. His contributions are poised to make a significant impact on the treatment of related diseases.